De audio van deze aflevering is mogelijk defect.
How to fix it?
OVER DEZE AFLEVERING
Virtual training and education has never been more important. Even before COVID-19, Osso VR identified a training gap for surgeons, nurses, OR staff, and surgical sales reps in North America. They created a technology to address the surgical training gap which uses virtual reality to improve patient outcomes, increase the adoption of higher-value medical technologies and provide access to critical education globally.
On today’s episode of the platform, we discuss the business of Osso VR with its founder and practicing orthopedic surgeon, Justin Barad, MD. Justin chats with Erica and Adam about the evolution of his business from its embryonic phase to its current stage as a growing and well-funded technology company.
Engels
Canada
OUDE AFLEVERINGEN ZOEKEN
Zoek naar eerdere afleveringen van The Platform.
ANDERE AFLEVERINGEN IN DEZE PODCAST
In this episode, Adam and Erica are joined by Jim Gale, the Founding Partner and Managing Director of Signet Healthcare Partners. He talks about the state of growth capital in the healthcare industry and how to access it.
[1:47] Tell us a little bit about yourself.
I graduated from the Universi…
In this episode of The Platform, Lise Pape, Founder and Managing Director of Walk With Path joins us to discuss how this new laser shoe technology is paving the way for people living with Parkinson’s Disease. As the company begins to seek investment, you’ll hear about the concept, the numbers, and …
Edward Cox, the Global Head of Digital Medicine and Executive VP of Strategic Alliances at Eversana, discusses current trends in the life sciences industry and the future of digital therapeutics.
Today’s guest is Nicholas Hall. He is the Executive Chairman, Founder, and Creative Solutions Director at Nicholas Hall Group of Companies.
[0:28] What is your background and what has your career path looked like?
I was the typical Proctor & Gamble intern after university. I didn’t think my…
Globally, the Coalition for Epidemic Preparedness Innovations (CEPI) has invested more than $23 million US towards the development of a vaccine for COVID-19 and, as of now, it is expected that around 20 companies have potential medicines in various stages of development, with at least four existing…
Disclaimer: De podcast en de illustraties die op deze pagina zijn ingesloten, zijn afkomstig van Sosna + Co, eigendom van de eigenaar en niet gelieerd aan of goedgekeurd door Listen Notes, Inc.
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .